Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer Survivors.

breast cancer cancer patients cancer survivors dietary changes eating habits survey health information

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2021
Historique:
received: 06 05 2021
accepted: 13 10 2021
entrez: 22 11 2021
pubmed: 23 11 2021
medline: 23 11 2021
Statut: epublish

Résumé

The role of a healthy diet in cancer prevention is well recognized. Recent data indicate that following the same advices can also improve cancer survivors' quality of life. Breast cancer (BC) patients are commonly concerned about diet and nutrition and frequently express the need to obtain health-related information and the will to change their diet and lifestyle. Hence, be aware of survivors' dietary changes and information needs is crucial for healthcare professionals to guide them toward optimal lifestyle choices. In order to investigate eating habits changes in a BC survivors' population, we conceived the cross-sectional multicentric study ECHO (Eating habits CHanges in Oncologic patients) Survey. Data were collected from 684 patients, diagnosed with invasive breast cancer, in order to investigate their changes in food consumption, use of supplements, or the beginning of a specific diet, after BC diagnosis. We also examined the sources of information used and if any modification in their diets was reported to the oncologist. We primarily observed that patients increased their consumption of vegetables, pulses, nuts, fruits, wholemeal bread/pasta, grains and fish; while decreasing red and processed meat, refined bread/pasta, baked good and animal fat consumption. Survivors also reported the use of dietary supplements, mainly vitamins, aimed at counteracting therapies' side effects. Changes in nutritional habits were often adopted without asking or informing the oncologist. Despite BC survivors made some positive changes in their nutritional habits, those modifications were mostly pursued by less than half of them, while the majority of patients consumed nutritional supplements after diagnosis. These results, as well as the failure to communicate with the physicians, reinforce the need to both improve the patient-healthcare professional relationship and to develop tailored nutrition counselling and intervention programs for cancer survivors.

Identifiants

pubmed: 34804915
doi: 10.3389/fonc.2021.705927
pmc: PMC8596328
doi:

Types de publication

Journal Article

Langues

eng

Pagination

705927

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2021 Caprara, Tieri, Fabi, Guarneri, Falci, Dieci, Turazza, Ballardini, Bin, Cinieri, Vici, Montagna, Zamagni, Mazzi, Modena, Marchetti, Verzè, Ghelfi, Titta, Nicolis and Gori.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Science. 2018 Jun 1;360(6392):962-963
pubmed: 29853672
Fam Med Community Health. 2019 Mar 8;7(2):e000057
pubmed: 32148704
J Acad Nutr Diet. 2021 Feb;121(2):233-241.e8
pubmed: 33109503
J Cancer Surviv. 2011 Sep;5(3):263-70
pubmed: 21505861
Int J Cancer. 2017 May 15;140(10):2220-2231
pubmed: 28260236
Nutrients. 2020 Dec 31;13(1):
pubmed: 33396551
Qual Life Res. 2003 May;12(3):229-38
pubmed: 12769135
Breast Cancer Res Treat. 2011 Jul;128(2):473-82
pubmed: 21221774
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
BMJ Open. 2018 Mar 27;8(3):e020313
pubmed: 29593021
Br J Cancer. 2014 Sep 23;111(7):1454-62
pubmed: 25101568
Obes Rev. 2011 Apr;12(4):282-94
pubmed: 20880127
World J Surg Oncol. 2019 Aug 31;17(1):153
pubmed: 31472677
Eur J Cancer Care (Engl). 2016 Sep;25(5):774-83
pubmed: 27349812
Curr Nutr Rep. 2016;5:9-17
pubmed: 27014505
Eur J Cancer. 2010 Sep;46(14):2555-62
pubmed: 20843485
CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74
pubmed: 22539238
Front Oncol. 2021 Jul 19;11:704893
pubmed: 34350120
Cancer Prev Res (Phila). 2018 Apr;11(4):171-184
pubmed: 29519885
Br J Cancer. 2011 Dec 6;105 Suppl 2:S2-5
pubmed: 22158314
Nutrients. 2019 Jul 03;11(7):
pubmed: 31277273
BMC Cancer. 2017 Dec 28;17(1):891
pubmed: 29282002
J Clin Oncol. 2016 Feb 20;34(6):611-35
pubmed: 26644543
Cancer. 2021 Jun 1;127(11):1827-1835
pubmed: 33524183
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Nutrition. 2018 Nov;55-56:140-145
pubmed: 30005330
Food Res Int. 2018 Feb;104:59-68
pubmed: 29433784
J Cancer Educ. 2016 Jun;31(2):348-57
pubmed: 25712202
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Int J Cancer. 2013 Jun 15;132(12):2918-27
pubmed: 23180513
Cancer Cell. 2020 Jun 8;37(6):767-785
pubmed: 32413275
Semin Cancer Biol. 2020 Feb;60:274-284
pubmed: 31491560
J Clin Oncol. 2005 Aug 20;23(24):5814-30
pubmed: 16043830
Curr Oncol Rep. 2019 Mar 27;21(5):41
pubmed: 30919143
Nutrients. 2020 Nov 05;12(11):
pubmed: 33167544

Auteurs

Greta Caprara (G)

Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milano, Italy.

Maria Tieri (M)

Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milano, Italy.
Fondazione Tera, Novara, Italy.

Alessandra Fabi (A)

Medical Oncology 1 - Istituto Nazionale Tumori Regina Elena Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy.
Precision Medicine in Breast Cancer Unit, Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy.

Valentina Guarneri (V)

Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Medical Oncology 2 - Istituto Oncologico Veneto Istituto Oncologico Veneto (IOV) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy.

Cristina Falci (C)

Medical Oncology 2 - Istituto Oncologico Veneto Istituto Oncologico Veneto (IOV) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy.

Maria Vittoria Dieci (MV)

Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Medical Oncology 2 - Istituto Oncologico Veneto Istituto Oncologico Veneto (IOV) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy.

Monica Turazza (M)

Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.

Bettina Ballardini (B)

Breast Division, MultiMedica Breast Unit Multimedica Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milano, Italy.

Alessandra Bin (A)

Dipartimento di Oncologia, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.

Saverio Cinieri (S)

Unità Operativa Complessa di Oncologia Medica, ASL Brindisi Senatore Antonio Perrino Hospital, Brindisi, Italy.

Patrizia Vici (P)

Unità Operativa Semplice Dipartimentale (UOSD), Sperimentazioni di FASE IV, Istituto Nazionale Tumori Regina Elena Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy.

Emilia Montagna (E)

Division of Medical Senology, Istituto Europeo di Oncologia (IEO), European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milano, Italy.

Claudio Zamagni (C)

Medical Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.

Cristina Mazzi (C)

Clinical Research Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.

Alessandra Modena (A)

Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.

Fabiana Marchetti (F)

Clinical Research Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.

Matteo Verzè (M)

Medical Direction, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.

Francesca Ghelfi (F)

Fondazione De Marchi-Department of Pediatrics, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
The Need For Nutrition Education/Innovation Programme (NNEdPro) Global Centre for Nutrition and Health, St John's Innovation Centre, Cambridge, United Kingdom.

Lucilla Titta (L)

Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milano, Italy.
Fondazione Tera, Novara, Italy.

Fabrizio Nicolis (F)

Associazione Italiana di Oncologia Medica (AIOM) Foundation Past President, Medical Direction, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.

Stefania Gori (S)

Associazione Italiana di Oncologia Medica (AIOM) Foundation President, Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.

Classifications MeSH